There’s been a nationwide recall for numerous bottles of Dynacare baby powder due to possible asbestos contamination.
Announced on Thursday, this recall includes 62 cases of baby powder manufactured by Dynarex Corporation. The affected products, identified by batch number B051, were distributed on or after March 11 across 12 states: Alabama, Arkansas, Colorado, Florida, Illinois, Kentucky, New Jersey, North Carolina, Pennsylvania, Tennessee, Washington, and Wisconsin. You can also find these products online on Amazon.com.
As per the Food and Drug Administration (FDA), asbestos is a natural mineral that can be found near talc, which is used in many cosmetic items. If talc mining isn’t done carefully or the ore isn’t properly purified, it can become contaminated with asbestos, said Dynarex.
The FDA stated, “The recall was initiated after routine testing showed that some finished products contained asbestos.” Dynarex has stopped distributing the product while an investigation into the contamination is ongoing.
Getty Images
According to the Agency for Toxic Substances and Disease Registry (ATSDR), prolonged exposure to asbestos can lead to serious health issues, including asbestosis, lung cancer, and mesothelioma, a lung cancer type that might take decades to develop after exposure.
Asbestos can not only be found in minerals like talc but is also still present in some older buildings. Exposure usually occurs when tiny asbestos fibers, invisible to the naked eye, are inhaled.
The baby powder in question comes in 14-ounce plastic bottles with an expiration date of December 28, 2026, located on the bottom. Fortunately, there have been no reports of illnesses tied to the affected products.
If you’ve purchased the recalled baby powder, stop using it right away and return it for a full refund. For questions, you can contact Dynarex Corporation at 888-396-2739 or 845-365-8200 between 8:30 a.m. and 5 p.m. EST. You can also reach out via email at [email protected].
Dynarex encourages health professionals and consumers to report any adverse events using the FDA’s MedWatch Adverse Event Reporting program. You can submit reports online through this link.